Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A versatile salt-based method to immobilize glycosaminoglycans and create growth factor gradients.

Hof DJ, Versteeg EMM, van de Lest CHA, Daamen WF, van Kuppevelt TH.

Glycoconj J. 2019 Jun;36(3):227-236. doi: 10.1007/s10719-019-09872-4. Epub 2019 May 4.

2.

Dynamic Expression of Genes Involved in Proteoglycan/Glycosaminoglycan Metabolism during Skin Development.

Uijtdewilligen PJE, Versteeg EM, van de Westerlo EMA, van der Vlag J, Daamen WF, van Kuppevelt TH.

Biomed Res Int. 2018 Aug 29;2018:9873471. doi: 10.1155/2018/9873471. eCollection 2018.

3.

Sequencing of glycosaminoglycans with potential to interrogate sequence-specific interactions.

van Kuppevelt TH, Oosterhof A, Versteeg EMM, Podhumljak E, van de Westerlo EMA, Daamen WF.

Sci Rep. 2017 Nov 1;7(1):14785. doi: 10.1038/s41598-017-15009-0.

4.

Bladder Regeneration Using Multiple Acellular Scaffolds with Growth Factors in a Bladder.

Roelofs LAJ, de Jonge PKJD, Oosterwijk E, Tiemessen DM, Kortmann BBM, de Gier RPE, Versteeg EMM, Daamen WF, van Kuppevelt TH, Geutjes PJ, Feitz WFJ.

Tissue Eng Part A. 2018 Jan;24(1-2):11-20. doi: 10.1089/ten.TEA.2016.0356. Epub 2017 May 2.

PMID:
28322621
5.

Visualisation of newly synthesised collagen in vitro and in vivo.

Oostendorp C, Uijtdewilligen PJ, Versteeg EM, Hafmans TG, van den Bogaard EH, de Jonge PK, Pirayesh A, Von den Hoff JW, Reichmann E, Daamen WF, van Kuppevelt TH.

Sci Rep. 2016 Jan 7;6:18780. doi: 10.1038/srep18780.

6.

Impaired primary mouse myotube formation on crosslinked type I collagen films is enhanced by laminin and entactin.

Grefte S, Adjobo-Hermans MJW, Versteeg EMM, Koopman WJH, Daamen WF.

Acta Biomater. 2016 Jan;30:265-276. doi: 10.1016/j.actbio.2015.11.009. Epub 2015 Nov 7.

PMID:
26555376
7.

Differential Expression of Specific Dermatan Sulfate Domains in Renal Pathology.

Lensen JF, van der Vlag J, Versteeg EM, Wetzels JF, van den Heuvel LP, Berden JH, van Kuppevelt TH, Rops AL.

PLoS One. 2015 Aug 31;10(9):e0134946. doi: 10.1371/journal.pone.0134946. eCollection 2015.

8.

Biodistribution of size-selected lyophilisomes in mice.

van Bracht E, Raavé R, Perevyazko IY, Versteeg EM, Hafmans TG, Schubert US, Oosterwijk E, van Kuppevelt TH, Daamen WF.

Eur J Pharm Biopharm. 2015 Aug;94:141-51. doi: 10.1016/j.ejpb.2015.04.020. Epub 2015 May 5.

PMID:
25953331
9.

Collagen-Vicryl scaffolds for reconstruction of the diaphragm in a large animal model.

Brouwer KM, Daamen WF, Hoogenkamp HR, Geutjes PJ, de Blaauw I, Janssen-Kessels W, de Boode W, Versteeg E, Wijnen RM, Feitz WF, Wijnen M, van Kuppevelt TH.

J Biomed Mater Res B Appl Biomater. 2014 May;102(4):756-63.

PMID:
24843887
10.

'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.

van Wijk XM, Oosterhof A, Versteeg EM, van de Westerlo EM, van Kuppevelt TH.

Biochem J. 2014 Aug 1;461(3):461-8. doi: 10.1042/BJ20140355.

PMID:
24819558
11.

Towards embryonic-like scaffolds for skin tissue engineering: identification of effector molecules and construction of scaffolds.

Uijtdewilligen PJ, Versteeg EM, Gilissen C, van Reijmersdal SV, Schoppmeyer R, Wismans RG, Daamen WF, van Kuppevelt TH.

J Tissue Eng Regen Med. 2016 Jan;10(1):E34-44. doi: 10.1002/term.1725. Epub 2013 Mar 7.

PMID:
23468399
12.

Extraction and structural analysis of glycosaminoglycans from formalin-fixed, paraffin-embedded tissues.

van Wijk XM, Vallen MJ, van de Westerlo EM, Oosterhof A, Hao W, Versteeg EM, Raben J, Wismans RG, Smetsers TF, Dijkman HB, Schalkwijk J, van Kuppevelt TH.

Glycobiology. 2012 Dec;22(12):1666-72. doi: 10.1093/glycob/cws119. Epub 2012 Aug 2.

PMID:
22859440
13.

Construction of a microstructured collagen membrane mimicking the papillary dermis architecture and guiding keratinocyte morphology and gene expression.

Lammers G, Roth G, Heck M, Zengerle R, Tjabringa GS, Versteeg EM, Hafmans T, Wismans R, Reinhardt DP, Verwiel ET, Zeeuwen PL, Schalkwijk J, Brock R, Daamen WF, van Kuppevelt TH.

Macromol Biosci. 2012 May;12(5):675-91. doi: 10.1002/mabi.201100443. Epub 2012 Mar 13.

PMID:
22416023
14.

A comparison of seven methods to analyze heparin in biomaterials: quantification, location, and anticoagulant activity.

Lammers G, van de Westerlo EM, Versteeg EM, van Kuppevelt TH, Daamen WF.

Tissue Eng Part C Methods. 2011 Jun;17(6):669-76. doi: 10.1089/ten.tec.2011.0010. Epub 2011 Apr 10.

PMID:
21375408
15.

Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cells.

den Dekker E, Grefte S, Huijs T, ten Dam GB, Versteeg EM, van den Berk LC, Bladergroen BA, van Kuppevelt TH, Figdor CG, Torensma R.

J Immunol. 2008 Mar 15;180(6):3680-8.

16.

Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (beta4GalT-7) deficient form of Ehlers-Danlos syndrome.

Götte M, Spillmann D, Yip GW, Versteeg E, Echtermeyer FG, van Kuppevelt TH, Kiesel L.

Hum Mol Genet. 2008 Apr 1;17(7):996-1009. Epub 2007 Dec 24.

PMID:
18158310
17.

Aberrant fibrillin-1 expression in early emphysematous human lung: a proposed predisposition for emphysema.

Robbesom AA, Koenders MM, Smits NC, Hafmans T, Versteeg EM, Bulten J, Veerkamp JH, Dekhuijzen PN, van Kuppevelt TH.

Mod Pathol. 2008 Mar;21(3):297-307. Epub 2007 Dec 14.

18.

Selection and characterization of a unique phage display-derived antibody against dermatan sulfate.

Lensen JF, Wijnhoven TJ, Kuik LH, Versteeg EM, Hafmans T, Rops AL, Pavao MS, van der Vlag J, van den Heuvel LP, Berden JH, van Kuppevelt TH.

Matrix Biol. 2006 Sep;25(7):457-61. Epub 2006 Jun 30.

PMID:
16934446
19.

3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.

Ten Dam GB, Kurup S, van de Westerlo EM, Versteeg EM, Lindahl U, Spillmann D, van Kuppevelt TH.

J Biol Chem. 2006 Feb 24;281(8):4654-62. Epub 2005 Dec 22.

20.

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency.

Stolk J, Veldhuisen B, Annovazzi L, Zanone C, Versteeg EM, van Kuppevelt TH, Berden JH, Nieuwenhuizen W, Iadarola P, Luisetti M.

Respir Res. 2005 May 31;6:47. Erratum in: Respir Res. 2006;7(1):20. Berden, Jo H M [added].

21.

Hypoxia-induced dysfunction of rat diaphragm: role of peroxynitrite.

Zhu X, Heunks LM, Versteeg EM, van der Heijden HF, Ennen L, van Kuppevelt TH, Vina J, Dekhuijzen PN.

Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L16-26. Epub 2004 Sep 10.

22.

Heterogeneity of heparan sulfates in human lung.

Smits NC, Robbesom AA, Versteeg EM, van de Westerlo EM, Dekhuijzen PN, van Kuppevelt TH.

Am J Respir Cell Mol Biol. 2004 Feb;30(2):166-73. Epub 2003 Aug 1.

PMID:
12896874
23.

Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma.

Smetsers TF, van de Westerlo EM, ten Dam GB, Clarijs R, Versteeg EM, van Geloof WL, Veerkamp JH, van Muijen GN, van Kuppevelt TH.

Cancer Res. 2003 Jun 1;63(11):2965-70.

24.

Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data.

Robbesom AA, Versteeg EM, Veerkamp JH, van Krieken JH, Bulten HJ, Smits HT, Willems LN, van Herwaarden CL, Dekhuijzen PN, van Kuppevelt TH.

Mod Pathol. 2003 Jan;16(1):1-7.

25.

Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies.

Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, van Kuppevelt TH.

J Biol Chem. 2002 Mar 29;277(13):10982-6. Epub 2002 Jan 14.

26.

Restoration by vacuum inflation of original alveolar dimensions in small human lung specimens.

van Kuppevelt TH, Robbesom AA, Versteeg EM, Veerkamp JE, van Herwaarden CL, Dekhuijzen PN.

Eur Respir J. 2000 Apr;15(4):771-7.

27.

Converging electroreceptor cells improve sensitivity and tuning.

Peters RC, Brans RJ, Bretschneider F, Versteeg E, Went A.

Neuroscience. 1997 Nov;81(1):297-301.

PMID:
9300422
28.

Caffeine reduces the efficacy of electroreceptor cell synapses: an electrophysiological single-unit in vivo study.

Peters RC, Versteeg E, Bretschneider F, Brans RJ, Went A.

Neuroscience. 1997 Jun;78(4):1229-38.

PMID:
9174089
29.

Induction of emphysematous lesions in rat lung by beta-D-xyloside, an inhibitor of proteoglycan synthesis.

van Kuppevelt TH, van de Lest CH, Versteeg EM, Dekhuijzen PN, Veerkamp JH.

Am J Respir Cell Mol Biol. 1997 Jan;16(1):75-84.

PMID:
8998082
30.

Altered composition of urinary heparan sulfate in patients with COPD.

van de Lest CH, Versteeg EM, Veerkamp JH, Berden JH, van den Born J, Heunks L, Lammers JW, van Herwaarden CL, Dekhuijzen PN, van Kuppevelt TH.

Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):952-8.

PMID:
8887591
31.

Elimination of autofluorescence in immunofluorescence microscopy with digital image processing.

Van de Lest CH, Versteeg EM, Veerkamp JH, Van Kuppevelt TH.

J Histochem Cytochem. 1995 Jul;43(7):727-30.

PMID:
7608528
32.

Digestion of proteoglycans in porcine pancreatic elastase-induced emphysema in rats.

van de Lest CH, Versteeg EM, Veerkamp JH, van Kuppevelt TH.

Eur Respir J. 1995 Feb;8(2):238-45.

33.

A spectrophotometric method for the determination of heparan sulfate.

van de Lest CH, Versteeg EM, Veerkamp JH, van Kuppevelt TH.

Biochim Biophys Acta. 1994 Nov 11;1201(2):305-11.

PMID:
7947946
34.

Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels.

van de Lest CH, Versteeg EM, Veerkamp JH, van Kuppevelt TH.

Anal Biochem. 1994 Sep;221(2):356-61.

PMID:
7529008
35.

Supplemental Content

Loading ...
Support Center